Cargando…
Pathology of rituximab-induced Kaposi sarcoma flare
BACKGROUND: Kaposi sarcoma (KS) flare may occur following therapy with corticosteroids, as part of the immune reconstitution inflammatory syndrome seen with highly active antiretroviral therapy (HAART), and after rituximab therapy. The exact mechanism responsible for iatrogenic KS flare is unclear....
Autores principales: | Pantanowitz, Liron, Früh, Klaus, Marconi, Sharon, Moses, Ashlee V, Dezube, Bruce J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515841/ https://www.ncbi.nlm.nih.gov/pubmed/18651955 http://dx.doi.org/10.1186/1472-6890-8-7 |
Ejemplares similares
-
Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
por: Pantanowitz, L, et al.
Publicado: (2009) -
Kaposi sarcoma in unusual locations
por: Pantanowitz, Liron, et al.
Publicado: (2008) -
Primary Kaposi sarcoma of the subcutaneous tissue
por: Pantanowitz, Liron, et al.
Publicado: (2008) -
Morphologic and immunophenotypic evidence of in-situ Kaposi's sarcoma
por: Konstantinopoulos, Panagiotis A, et al.
Publicado: (2006) -
KSHV infection of endothelial cells manipulates CXCR7-mediated signaling: implications for Kaposi’s Sarcoma progression and intervention
por: Vomaske, Jennifer, et al.
Publicado: (2012)